AACR 2024 | The key to precision medicine in colorectal cancer

Scott Kopetz, MD, PhD, The University of Texas MD Anderson Cancer Center, Houston, TX, discusses the route to precision medicine in colorectal cancer. The current use of biomarkers is helpful for predicting treatment response, but a greater emphasis on the dynamic nature of colorectal cancer may provide more effective treatments in the face of deviations in treatment responses. This interview took place at American Association for Cancer Research (AACR) Annual Meeting 2024 in San Diego, CA.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.